West Pharma (WST) Reports In-Line Q4 EPS, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
West Announces Fourth Quarter and Full-Year 2015 Results
February 18, 2016 7:00 AM ESTEXTON, PA -- (Marketwired) -- 02/18/16 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth quarter and full-year 2015 and provided detailed financial guidance for the year 2016.
Executive Summary
Fourth-quarter 2015 reported sales of $359.7 million grew 2.8% over the prior-year quarter. Net sales at constant currency grew by 9.7% for the quarter. Full-year 2015 sales of $1.4 billion declined by 1.5% due to currency, with net sales at constant currency growing 7.2%. Fourth-quarter 2015 reported diluted EPS was $0.45. On an adjusted basis, diluted EPS was $0.47 and grew 4% from the same period last... More